Nye Health × Waracle

Promoting diagnosis for early stage MCI and dementia

nye health

The Opportunity

Creating a structured process for new product development

With a 5 year R&D contract signed with Roche, Nye wanted to expand their solution offering but as a new startup, needed better product research and validation processes, and the benefit of experience to validate product ideas before construction. Ultimately, the objective was to deliver value to the client and users - but also to maintain engagement and motivation internally to create a sense of achievement for the team and its stakeholders.

Female surgeon doctor consults the mobile phone before operation.

The Solution

Creating enhanced engagement services for patients

Waracle provided Nye with “Product and Design as a service” spanning a variety of skill sets as needed across the engagement. The Waracle team worked at the senior leadership level to advise on the product strategy and direction, conducting extensive and compliant research to inform decisions on which features would proceed and which to delay or drop. Research involved finding patients and stakeholders with very specific sensitive backgrounds so was not taken lightly.

Client Image
Client Image

The Impact

Creation of a new engagement service for patients at the start of the condition work to promote diagnosis for early stage MCI and dementia. A defined product strategy and structured process for ongoing discovery, aligned with a new, rigorous research and analysis process to allow fast validation and adoption of new ideas.

Client Testimonial

"Thanks to Waracle, we were able to deliver work for a key partner and build capability within our team."

Alexander Finlayson, CEO

Insights

HealthTech

Shaping intelligent digital experiences in healthcare: The app will see you now

HealthTech

Mobile device sensors & the new era of health biomarkers

Healthtech

Healthcare AI & its moving target – high quality data